February 27, 2018: Former President of Houston-Based Drug Company Convicted in $50 Million Drug Diversion Scheme
Date of publication: 27-02-2018
February 27, 2018: Former President of Houston-Based Drug Company Convicted in $50 Million Drug Diversion Scheme Źródło: https://www.fda.gov
